Author/year/reference |
Patients / valves |
Success rate |
Approach |
30-day mortality |
Type of study |
Eltchaninoff 2011[19] |
244 ES68%, CV32% |
98.3% |
TV 71%
TA 29% |
12.7% |
Prospective multicenter national registry |
Ewe 2011[13] |
104 ES100% |
92.5% |
TV 44%
TA 56% |
9.6% TV 11.1% TA 8.5% |
Prospective single center with retrospective analysis |
Leon 2010 [11] |
173/358 ES100% |
95.4% |
TV 100% |
6.4% |
Prospective multicenter randomized trial |
Bosmans 2011[22] |
328 ES43%, CV57% |
97% |
TV 73%
TA 27% |
ES 12%
CV11% |
Prospective non-randomized multicenter national registry |
Buellesfeld 2011[10] |
126 CV100% |
83.1% |
TV100% |
15.2% |
Prospective multicenter study |
Conradi 2011[9] |
28 ES89%, CV11% |
96.4% |
TV 32.1% TA67.9% |
7.1% |
Case series: comparative study |
Bapat 2011[20] |
193 ES100% |
100% |
TV 44% TA 47.2% TAo 8.8% |
TA 7.7% TAo 11.8% |
Case series study |
Ben-Dor 2011[8] |
111 |
NA |
NA |
11.7% |
Prospective cohort study |
Johansson 2011[27] |
40 ES100% |
92.5% TV91% TA 93% |
TV 25% TA 75% |
5% |
Case comparative study |
Lopez-Otero 2011[12] |
186 CV100% |
98.8-100% |
TV 100% |
8.4% |
Multicenter study |
Bleiziffer 2009[15] |
137 ES17% CV83% |
98.5% |
TV 82%
TA 17%
TAo 1% |
12.4% |
Single center study |
Abdel-Wahab 2011[36] |
690/697 ES16% CV84% |
98.6% |
TV95.5% TA3.7% TAo0.7% |
6.7%-15.1% |
Multicenter prospective registry |
Grube 2011[24] |
60 CV100% |
96.7% |
TV100% |
6.7% |
Multicenter prospective pilot study |
Baan 2010[38] |
30 CV100% |
90% |
TV100% |
20% |
Single center study |
Piazza 2008 [42] |
646 CV100% |
97% |
|
8% |
Multicenter registry |
Dewey 2008 [21] |
21 ES100% |
NR |
TV TA |
9.5% |
Single center study |
Grube 2007[18]18 |
86 CV100% |
88% |
TV100% |
12% |
Multicenter study |
Webb 2007[17] |
50 ES100% |
86% |
TV100% |
12% |
Single center study |
Grube 2006[16] |
25 CV100% |
84% |
TV100% |
20% |
Single center prospective nonrandomised study |
TV=transvascular (transfemoral, transaxillary and subclavian artery); TA= transapical; NA: not available, TAo= transaortic, PCI= percutaneous coronary intervention, ES=
Edwards Sapien bioprosthesis, CV= CoreValve bioprosthesis, NR=not reported. |